Phase 1 Head and Neck Neoplasms Clinical Trials

5 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–5 of 5 trials

Recruiting

Phase 1Phase 2

Intratumoral N17350 in Advanced Solid Tumors

MelanomaCarcinoma, Non-Small Cell LungHead and Neck Neoplasms+4 more

Onchilles Pharma Inc275 enrolled1 locationNCT07339176

Recruiting

Phase 1

First in Human Study of AZD9592 in Solid Tumors

Carcinoma, Non-Small Cell LungColorectal NeoplasmsHead and Neck Neoplasms+1 more

AstraZeneca403 enrolled51 locationsNCT05647122

Recruiting

Phase 1

Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC

Head and Neck NeoplasmsNeoplasm MetastasisCarcinoma, Squamous Cell+3 more

University of Chicago36 enrolled1 locationNCT06912087

Recruiting

Phase 1

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Colorectal, CancerSquamous Cell Carcinoma of Head and NeckHead and Neck Squamous Cell Carcinoma+8 more

Bicara Therapeutics292 enrolled20 locationsNCT04429542

Recruiting

Phase 1Phase 2

HTL0039732 in Participants With Advanced Solid Tumours

SarcomaUrinary Bladder NeoplasmsUterine Cervical Neoplasms+11 more

Cancer Research UK150 enrolled5 locationsNCT05944237